Figure 5
Gastrointestinal AE discontinuations with different therapies in three analyses of trials lasting 4 to 12 weeks. AE, adverse event; NSAID, nonsteroidal anti-inflammatory drug.
Gastrointestinal AE discontinuations with different therapies in three analyses of trials lasting 4 to 12 weeks. AE, adverse event; NSAID, nonsteroidal anti-inflammatory drug.